SKIL and metastatic prostate carcinoma: Interestingly, all 5 SKIL-positive clinical samples with clinical information (two TCGA samples lacked clinical data) contained a Gleason grade 5 component or represented metastatic prostate cancer, suggesting that SKIL-activating alterations may associate with high-grade prostate cancer.